Dr. Reddy's and Alvotech have partnered to co-develop a biosimilar of Keytruda, Merck's $29.5 billion cancer drug, boosting ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Alvotech and Dr. Reddy's collaborate to develop biosimilar Keytruda, expanding global access to cancer treatment options.

Shares of Dr. Reddy’s Laboratories Ltd ADR (NYSE:RDY) climbed 3.1% in premarket trading today following the announcement of a collaboration and license agreement with Alvotech to co-develop, ...

On Thursday, 2257 stocks advanced, 1725 declined and 147 remained unchanged on Bombay Stock Exchange with advance decline ...

The Delhi Police has busted a racket selling spurious anti-cancer drugs and arrested six men who targeted patients through ...

The domestic equity indices closed with strong gains today, extending their rally for a second straight session. The uptrend was driven by positive global cues and the return of foreign fund inflows ...

Pharmaceutical tariffs should absolutely target adversarial nations like China — but they shouldn't be applied ...